San Francisco, CA, United States of America

Priscilla M Van Dyke

This inventor holds 17 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 7 EPO patents. Top assignees: Theravance, Inc., Theravance Biopharma R&d IP, LLC. Active years: 2009-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Priscilla M Van Dyke. Retrieved from https://idiyas.com/inventor/priscilla-m-van-dyke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 2)

% Patents Active = 29.4

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 7 (Patent Applications = 2)

Average Co-Inventor Count = 5.4

ph-index = 8

Forward Citations = 146(Granted Patents)

Location History:

Berkeley, CA (US) (2009)
San Francisco, CA (US) (2010 - 2020)

Company Filing History:

Theravance Biopharma R&d IP, LLC

patents

Years Active: 2009-2020

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10745394 - 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists (2020-08-18),

2. 9227933 - 3-phenoxymethylpyrrolidine compounds (2016-01-05),

3. 8933249 - 3-(phenoxyphenylmethyl)pyrrolidine compounds (2015-01-13),

4. 8703791 - 3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists (2014-04-22),

5. 8518966 - Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists (2013-08-27),

6. 8481563 - 8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists (2013-07-09),

7. 8318765 - 3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists (2012-11-27),

8. 8263618 - 8-azabicyclo[3.2.1]octane compounds as MU opioid receptor antagonists (2012-09-11),

9. 8242164 - 3-(phenoxyphenylmethyl)pyrrolidine compounds (2012-08-14),

10. 8211894 - Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists (2012-07-03),

11. 8106232 - 3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists (2012-01-31),

12. 7994209 - 3-phenoxymethylpyrrolidine compounds (2011-08-09),

13. 7902221 - Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists (2011-03-08),

14. 7902220 - 8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists (2011-03-08),

15. 7888386 - 3-(phenoxyphenylmethyl)pyrrolidine compounds (2011-02-15),

Title: Priscilla M Van Dyke: A Trailblazing Inventor in Pharmaceutical Innovation

Introduction

Priscilla M Van Dyke, based in San Francisco, California, is a notable inventor with a remarkable portfolio of 17 patents. Her contributions to the field of pharmacology have paved the way for innovative therapies and treatments that address critical health conditions.

Latest Patents

Among her latest inventions, Priscilla has developed novel 8-azabicyclo[3.2.1]octane compounds that act as mu opioid receptor antagonists. This invention includes pharmaceutical compositions that utilize these compounds to treat conditions associated with mu opioid receptor activity. Additionally, she has created 3-phenoxymethylpyrrolidine compounds that serve as serotonin and norepinephrine reuptake inhibitors. Both innovations underscore her dedication to advancing therapeutic options in the pharmaceutical landscape.

Career Highlights

Priscilla's professional journey features significant tenures at leading organizations, including Theravance, Inc. and Theravance Biopharma R&D IP, LLC. Her experience in these companies has been crucial in shaping her expertise in drug development and patent innovation, positioning her as a key player in the industry.

Collaborations

Throughout her career, Priscilla has collaborated with esteemed colleagues, including Daisuke Roland Saito and Daniel D Long. These partnerships have not only enriched her work but have also fostered an environment of creativity and innovation in pharmaceutical research.

Conclusion

Priscilla M Van Dyke exemplifies the spirit of innovation through her impactful inventions and collaborative efforts in the pharmaceutical sector. Her commitment to enhancing healthcare through science and research continues to inspire future generations of inventors and researchers.

Profile summary based on public USPTO records.